Patricia Dauer Selected Research

Patricia Dauer Research Topics

12	Neoplasms (Cancer) 12/2022 - 08/2016
9	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 08/2016
4	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2022
3	Hypoxia (Hypoxemia) 01/2019 - 01/2017
2	Pathologic Complete Response 01/2024 - 12/2023
2	Neoplasm Metastasis (Metastasis) 12/2019 - 12/2018
2	Tics (Tic) 12/2018 - 11/2017
1	COVID-19 03/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017
1	Adenocarcinoma 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017

4	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2017
3	14-O-phosphonooxymethyltriptolide disodium saltIBA 01/2018 - 01/2017
3	triptolideIBA 11/2017 - 12/2016
2	Phenobarbital (Luminal)FDA Link 12/2022 - 09/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2019
2	Endoplasmic Reticulum Chaperone BiPIBA 12/2019 - 01/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2017
2	NF-kappa B (NF-kB)IBA 11/2017 - 12/2016
2	ProdrugsIBA 11/2017 - 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	pertuzumabIBA 09/2022
1	human ERBB2 proteinIBA 09/2022
1	Trastuzumab (Herceptin)FDA Link 09/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2019
1	O-GlcNAc transferaseIBA 01/2019
1	GlycogenIBA 01/2019
1	CholesterolIBA 12/2018
1	EnzymesIBA 12/2018
1	LipidsIBA 12/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018
1	CaveolinsIBA 12/2018
1	AntioxidantsIBA 01/2018
1	CytokinesIBA 01/2017
1	CalciumIBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	DiterpenesIBA 01/2017
1	Nerve Growth Factor (NGF)IBA 12/2016
1	BAY 11-7085IBA 12/2016